iShares MSCI Germany (DAX) vs Iovance Biotherapeutics Inc. Common Stock — how do they compare? iShares MSCI Germany (DAX) trades at $40.96 (market cap $1.42B), while Iovance Biotherapeutics Inc. Common Stock trades at $14.62 (market cap $6.04B). The key difference: Iovance Biotherapeutics Inc. Common Stock is far larger — about 4.3× iShares MSCI Germany (DAX)'s market cap, and Iovance Biotherapeutics Inc. Common Stock is trading nearer its 52-week high, iShares MSCI Germany (DAX) nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Germany (DAX) for 54 Days and Iovance Biotherapeutics Inc. Common Stock for 0 Days on average.
| EWG | IOVA | |
|---|---|---|
Market Cap | $1.42B | $6.04B |
Volume | 1,110,573 | 14,805,993 |
Sector | Broad Market / Factor | Health |
52-Week High | $44.59 | $14.82 |
52-Week Low | $38.08 | $1.81 |
Typical Hold Time | 54 Days | 0 Days |
Enterprise Value | — | $5.97B |
Signals from Pluang's Aura AI — not financial advice
EWG trades at $40.96 with minimal daily movement (+0.12%). Technical indicators show a bearish trend with strong selling pressure across moving averages and oscillators, though RSI levels suggest potential oversold conditions. The stock faces resistance at $41 with support at $40. Recent European market news highlights mixed sentiment with resilient equities but concerns about ECB rate hikes and energy-driven inflation pressures.
The outlook remains cautious due to bearish technicals and macroeconomic headwinds from potential ECB tightening. Investment opportunity exists if oversold RSI levels trigger a rebound, but risks include further rate hikes and energy price volatility. Stock performance hinges on European economic stability and inflation control.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →Iovance Biotherapeutics develops cell therapies for cancer. Its approach uses tumor-infiltrating lymphocytes, or TIL, to target solid tumors.
Read more on IOVA →